BRCA1 and breast carcinoma: These are largely women with “moderate penetrance” mutations, but even women with BRCA1 or 2 mutations may not be identified.19–22 There is an unmet challenge to improve our identification and diagnosis of patients who have an inherited increased lifetime risk of breast cancer.